Authors: Mark Terry Published: Mar 01, 2022 BIOSPACE Pfizer-BioNTech Vaccine Only 12% Effective Against Omicron in 5-11-Year-Olds In a new study that is yet to be peer-reviewed, the New York State Department of Health found that the Pfizer–BioNTech vaccine was only about 12% effective for children ages 5 to 11 years against the Omicron variant. In that age group, it […]
Current Issues In Molecular Biology Authors: Markus Aldén 1 , Francisko Olofsson Falla 1 , Daowei Yang 1 , Mohammad Barghouth 1 , Cheng Luan 1 , Magnus Rasmussen 2 and Yang De Marinis 1,* Abstract: Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer andBioNTech, showed reversible hepatic effects in animals that received […]
Authors: Jim Hoft Published May 3, 2022 A new German study with around 40,000 participants concluded that severe complications after receiving the COVID vaccine. The study found that those suffering serious complications is 40 times higher than previously recorded. “The number of severe complications after vaccination against Sars-CoV-2 is 40 times higher than previously recorded […]
A new Danish study reveals disparities in all-cause mortality between mRNA and adenovirus vaccines Do the covid vaccines save lives? That is the question on many people’s minds, that has led to heated discussions across the world. A bombshell new study by a distinguished team of Danish researchers led by Prof. Christine Stabell-Benn suggests a surprisingly nuanced […]
Authors: T. Beaney, A. L. Neves, A. Alboksmaty, H. Ashrafian, K. Flott, A. Fowler, J. R. Benger, P. Aylin, S. Elkin, A. Darzi & J. Clarke Nature Communications volume 13, Article number: 2356 (2022) Abstract The Covid-19 mortality rate varies between countries and over time but the extent to which this is explained by the underlying risk in those infected is unclear. Using data on all adults in England with […]
Last updated April 28, 2022 This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group in collaboration with Laura E. Riley, MD; Richard Beigi, MD; Denise J. Jamieson, MD, MPH; Brenna L. Hughes, MD, MSc; Geeta Swamy, MD; Linda O’Neal Eckert, MD; […]
Paxlovid, authorized to treat high-risk people early in infection, didn’t meaningfully reduce illness in exposed adults Authors: Jared S. Hopkins Apr. 29, 2022 The Wall Street Journal The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found. Pfizer said Friday that the […]
Authors: Fenit Nirappil and Dan Keating, The Washington PostApril 29, 2022 Unvaccinated people accounted for the overwhelming majority of deaths in the United States throughout much of the coronavirus pandemic. But that has changed in recent months, according to a Washington Post analysis of state and federal data. The pandemic’s toll is no longer falling almost […]
Authors: Mint Newsletters April 29, 2022 The BA.4 and BA.5 sublineages appear to be more infectious than the earlier BA.2 lineage The sub-lineages have been detected in seven of South Africa’s nine provinces and 20 countries worldwide New omicron sublineages, discovered by South African scientists this month, are likely able to evade vaccines and natural […]
